Abstract

An electrodeposited gold@poly-luminol nanocomposite on glassy carbon electrode (Au@PL-NC/GCE) has been developed and demonstrated as solid-state electrochemiluminescence (ECL) immunosensor platform for prostate specific antigen (PSA) sensing. In-situ electro-generated reactive oxygen species (ROS) from oxygen reduction reaction in oxygen saturated PBS (pH 7.4) acts as sole co-reactant augmenting the signal transduction. Protein-G bio-affinity layer interfaced with Au@PL-NC/GCE (Protein-G/Au@PL-NC/GCE) to support the effective localization of Fc region of the monoclonal antibodies of PSA (mAb-PSA). As-developed ECL probe exhibit selective recognition of target analyte, PSA, enabling wide linearity of 1 fg mL−1 to 10 μg mL−1 with a calculated limit of detection (LOD) and limit of quantification (LOQ) of 0.45 fg mL−1 and 1.37 fg mL−1, respectively. The selectivity and specificity of the ECL probe was tested using human serum albumin, immunoglobulin G and mixtures of the same with target analyte. Fabricated ECL probe not only exhibit high sensitivity and specificity against commercial PSA samples but also enable clinical detection in real human serum and urine samples with acceptable recovery range from 97% to 103%. Our results suggest that the fabricated reagent-less solid-state ECL platform holds promising application in the field of prostate oncological screening and its point-of-care applications.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call